Abstract
Every January, the American Diabetes Association (ADA) publishes its Standards of Medical Care in Diabetes. Health care professionals with an interest in diabetes anxiously await this publication to learn of updates and changes in the management and care for people with diabetes. This year, the updates and changes are minimal for most sections of the Standards. However, several changes are significant; specifically, the updates to the pharmacologic approaches to glycemic treatment section. No longer is metformin the sole option for first-line therapy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have